Should I buy or sell Apyx Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" APYX shares. View APYX analyst ratings or view top-rated stocks .

What is Apyx Medical's stock price target for 2024?

2 brokerages have issued twelve-month price targets for Apyx Medical's shares. Their APYX share price targets range from $4.50 to $9.00. On average, they expect the company's share price to reach $6.17 in the next twelve months. This suggests a possible upside of 367.2% from the stock's current price. View analysts price targets for APYX or view top-rated stocks among Wall Street analysts .

How have APYX shares performed in 2024?

Apyx Medical's stock was trading at $2.62 at the beginning of the year. Since then, APYX shares have decreased by 49.6% and is now trading at $1.32. View the best growth stocks for 2024 here .

Are investors shorting Apyx Medical?

Apyx Medical saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 706,700 shares, a decline of 55.0% from the March 15th total of 1,570,000 shares. Based on an average trading volume of 160,300 shares, the days-to-cover ratio is presently 4.4 days. Approximately 2.5% of the shares of the company are short sold. View Apyx Medical's Short Interest .

When is Apyx Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our APYX earnings forecast .

How were Apyx Medical's earnings last quarter?

Apyx Medical Co. (NASDAQ:APYX) released its quarterly earnings results on Thursday, March, 21st. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $14.66 million for the quarter, compared to analysts' expectations of $14.40 million. Apyx Medical had a negative trailing twelve-month return on equity of 54.90% and a negative net margin of 35.75%.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical updated its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $49.7 million-$52.9 million, compared to the consensus revenue estimate of $59.8 million.

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN) , Johnson & Johnson (JNJ) , ONEOK (OKE) , Occidental Petroleum (OXY) , Procter & Gamble (PG) , STORE Capital (STOR) , Wells Fargo & Company (WFC) , Boeing (BA) , Bank of America (BAC) and Delta Air Lines (DAL) .

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Silverberg Bernstein Capital Management LLC (1.79%). Insiders that own company stock include Charles D Goodwin II, Matthew C Hill and Todd Hornsby. View institutional ownership trends .

How do I buy shares of Apyx Medical?

Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:APYX

Apyx Medical (APYX) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

Free APYX Stock Alerts

$1.32

-0.07 (-5.04%)

(As of 04/17/2024 ET)

Compare

Today's Range: $1.28
▼
$1.44
50-Day Range: $1.25
▼
$2.71
52-Week Range: $1.21
▼
$7.97

Volume: 89,880 shs
Average Volume: 149,363 shs
Market Capitalization: $45.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.17

Get Apyx Medical alerts:

Apyx Medical MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 367.2% Upside
$6.17 Price Target
Short Interest: Healthy
2.49% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.07
Upright™ Environmental Score
News Sentiment: 0.32
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.74) to ($0.58) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.17 out of 5 stars

Medical Sector

123rd out of 912 stocks

Medical Devices Industry

1st out of 4 stocks

3.5

Analyst's Opinion

Consensus Rating
Apyx Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Apyx Medical has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
2.49% of the float of Apyx Medical has been sold short.
Short Interest Ratio / Days to Cover
Apyx Medical has a short interest ratio ("days to cover") of 4.4.
Change versus previous month
Short interest in Apyx Medical has recently decreased by 54.99%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Apyx Medical does not currently pay a dividend.
Dividend Growth
Apyx Medical does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Apyx Medical has received a 60.75% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Electrosurgical devices" product. See details.
Environmental Sustainability
The Environmental Impact score for Apyx Medical is -1.07.

2.4

News and Social Media Coverage

News Sentiment
Apyx Medical has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Apyx Medical this week, compared to 2 articles on an average week.
Search Interest
Only 4 people have searched for APYX on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
MarketBeat Follows
3 people have added Apyx Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Apyx Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
13.10% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Apyx Medical are expected to grow in the coming year, from ($0.74) to ($0.58) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Apyx Medical is -2.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Apyx Medical is -2.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Apyx Medical has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About Apyx Medical Stock (NASDAQ:APYX)

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

APYX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

APYX Stock News Headlines

April 17, 2024 | finance.yahoo.com

Ocean Drive Plastic Surgery Founder Dr. Alan Durkin Appointed VIO Med Spa Chief Medical Officer

April 11, 2024 | finance.yahoo.com

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit

April 18, 2024 | Market Moving Trends (Ad)

Top 5 AI Stocks to Buy for 2024

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

April 11, 2024 | businesswire.com

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

March 26, 2024 | finance.yahoo.com

Downgrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near Term

March 23, 2024 | seekingalpha.com

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

March 23, 2024 | finance.yahoo.com

Apyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Cutting Their Estimates

March 22, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)

April 18, 2024 | Market Moving Trends (Ad)

Top 5 AI Stocks to Buy for 2024

March 22, 2024 | finance.yahoo.com

Apyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call Transcript

March 22, 2024 | finance.yahoo.com

Further weakness as Apyx Medical (NASDAQ:APYX) drops 22% this week, taking three-year losses to 87%

March 22, 2024 | markets.businessinsider.com

Apyx Medical (APYX) Receives a Hold from JMP Securities

March 21, 2024 | finance.yahoo.com

Q4 2023 Apyx Medical Corp Earnings Call

March 21, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Apyx Medical (APYX)

March 21, 2024 | investorplace.com

APYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023

March 21, 2024 | msn.com

Apyx Medical reports mixed Q4 results; initiates FY24 outlook

March 21, 2024 | washingtonpost.com

Apyx: Q4 Earnings Snapshot

March 21, 2024 | businesswire.com

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

March 16, 2024 | finance.yahoo.com

APYX Apr 2024 5.000 put

March 4, 2024 | businesswire.com

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

March 4, 2024 | businesswire.com

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

February 27, 2024 | markets.businessinsider.com

Craig-Hallum Gives a Buy Rating to Codexis (CDXS)

February 21, 2024 | finance.yahoo.com

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

February 21, 2024 | businesswire.com

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

February 8, 2024 | finance.yahoo.com

Favourable Signals For Apyx Medical: Numerous Insiders Acquired Stock

February 6, 2024 | morningstar.com

Apyx Medical Corp

January 22, 2024 | seekingalpha.com

Apyx stock rises on publication of Renuvion safety analysis

See More Headlines

Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/21/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: NASDAQ:APYX
CUSIP: N/A
CIK: 719135
Web: www.apyxmedical.com
Phone: (727) 384-2323
Fax: 800-323-1640
Employees: 252
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $6.17
High Stock Price Target: $9.00
Low Stock Price Target: $4.50
Potential Upside/Downside: +367.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.54)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,710,000.00
Net Margins: -35.75%
Pretax Margin: -40.65%
Return on Equity: -54.90%
Return on Assets: -28.41%

Debt

Debt-to-Equity Ratio: 1.23
Current Ratio: 5.52
Quick Ratio: 4.74

Sales & Book Value

Annual Sales: $52.35 million
Price / Sales: 0.87
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.78 per share
Price / Book: 1.69

Miscellaneous

Outstanding Shares: 34,644,000
Free Float: 30,106,000
Market Cap: $45.73 million
Optionable: Optionable
Beta: 1.09

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Charles D. Goodwin II (Age 57)
President, CEO & Director
Comp: $813.13k
Mr. Matthew C. Hill CPA (Age 55)
CFO, Treasurer & Secretary
Comp: $445.95k
Mr. Moshe Citronowicz (Age 71)
Senior Vice President
Comp: $405.47k
Mr. Todd Hornsby (Age 47)
Executive Vice President
Comp: $561.77k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

APYX Stock Analysis - Frequently Asked Questions

Should I buy or sell Apyx Medical stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" APYX shares.
View APYX analyst ratings or view top-rated stocks.
What is Apyx Medical's stock price target for 2024?: 2 brokerages have issued twelve-month price targets for Apyx Medical's shares. Their APYX share price targets range from $4.50 to $9.00. On average, they expect the company's share price to reach $6.17 in the next twelve months. This suggests a possible upside of 367.2% from the stock's current price.
View analysts price targets for APYX or view top-rated stocks among Wall Street analysts.
How have APYX shares performed in 2024?: Apyx Medical's stock was trading at $2.62 at the beginning of the year. Since then, APYX shares have decreased by 49.6% and is now trading at $1.32.
View the best growth stocks for 2024 here.
Are investors shorting Apyx Medical?: Apyx Medical saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 706,700 shares, a decline of 55.0% from the March 15th total of 1,570,000 shares. Based on an average trading volume of 160,300 shares, the days-to-cover ratio is presently 4.4 days. Approximately 2.5% of the shares of the company are short sold.
View Apyx Medical's Short Interest.
When is Apyx Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our APYX earnings forecast.
How were Apyx Medical's earnings last quarter?: Apyx Medical Co. (NASDAQ:APYX) released its quarterly earnings results on Thursday, March, 21st. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $14.66 million for the quarter, compared to analysts' expectations of $14.40 million. Apyx Medical had a negative trailing twelve-month return on equity of 54.90% and a negative net margin of 35.75%.

What guidance has Apyx Medical issued on next quarter's earnings?: Apyx Medical updated its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $49.7 million-$52.9 million, compared to the consensus revenue estimate of $59.8 million.
What other stocks do shareholders of Apyx Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL).
Who are Apyx Medical's major shareholders?: Apyx Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Silverberg Bernstein Capital Management LLC (1.79%). Insiders that own company stock include Charles D Goodwin II, Matthew C Hill and Todd Hornsby.
View institutional ownership trends.
How do I buy shares of Apyx Medical?: Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:APYX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial